These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 26209732)

  • 1. Drugs meeting the molecular basis of diabetic kidney disease: bridging from molecular mechanism to personalized medicine.
    Lambers Heerspink HJ; Oberbauer R; Perco P; Heinzel A; Heinze G; Mayer G; Mayer B
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv105-112. PubMed ID: 26209732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using systems biology to evaluate targets and mechanism of action of drugs for diabetes comorbidities.
    Mayer B
    Diabetologia; 2016 Dec; 59(12):2503-2506. PubMed ID: 27376542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is personalized medicine a dream or a reality?
    Morse BL; Kim RB
    Crit Rev Clin Lab Sci; 2015 Feb; 52(1):1-11. PubMed ID: 25181036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic signatures in the treatment of stroke.
    Munshi A; Sharma V
    Curr Pharm Des; 2015; 21(3):343-54. PubMed ID: 25163728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An integrative systems biology approach for precision medicine in diabetic kidney disease.
    Mulder S; Hamidi H; Kretzler M; Ju W
    Diabetes Obes Metab; 2018 Oct; 20 Suppl 3(Suppl 3):6-13. PubMed ID: 30294956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update of pathophysiology and management of diabetic kidney disease.
    Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
    J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular pharmacogenetics: a promise for genomically-guided therapy and personalized medicine.
    Zaiou M; El Amri H
    Clin Genet; 2017 Mar; 91(3):355-370. PubMed ID: 27714756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision medicine: The future in diabetes care?
    Scheen AJ
    Diabetes Res Clin Pract; 2016 Jul; 117():12-21. PubMed ID: 27329017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomic biomarkers for personalized cancer treatment.
    Rodríguez-Antona C; Taron M
    J Intern Med; 2015 Feb; 277(2):201-217. PubMed ID: 25338550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on systems biology applications in diabetic kidney disease.
    Komorowsky CV; Brosius FC; Pennathur S; Kretzler M
    J Cardiovasc Transl Res; 2012 Aug; 5(4):491-508. PubMed ID: 22733404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenomic Biomarkers for Improved Drug Therapy-Recent Progress and Future Developments.
    Lauschke VM; Milani L; Ingelman-Sundberg M
    AAPS J; 2017 Nov; 20(1):4. PubMed ID: 29181807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on glycemic control for the treatment of diabetic kidney disease.
    Nadkarni GN; Yacoub R; Coca SG
    Curr Diab Rep; 2015 Jul; 15(7):42. PubMed ID: 25971619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Pharmacogenomics in Personalized Medicine.
    Singh DB
    Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing personalized medicine in diabetic kidney disease: Stakeholders' perspectives.
    de Vries JK; Levin A; Loud F; Adler A; Mayer G; Pena MJ
    Diabetes Obes Metab; 2018 Oct; 20 Suppl 3(Suppl Suppl 3):24-29. PubMed ID: 30294955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in epilepsy.
    Balestrini S; Sisodiya SM
    Neurosci Lett; 2018 Feb; 667():27-39. PubMed ID: 28082152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized medicine, pharmacogenomic and companion biomarker.
    Manceau H; Amrani K; Peoc'h K
    Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [State of the art of pharmacogenetic diagnostics in drug therapy].
    Kirchheiner J; Seeringer A; Brockmöller J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2006 Oct; 49(10):995-1003. PubMed ID: 17013776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine, genomics, and pharmacogenomics: a primer for nurses.
    Blix A
    Clin J Oncol Nurs; 2014 Aug; 18(4):437-41. PubMed ID: 25095297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.